Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cone

Showing results (351-360 of 368) with videos related to

Pageof 37
Sort By:
Drug and Alcohol Dependence|May 29, 2025
Corrigendum to "A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults" [Drug Alcohol Depend. 272 (2025) 112676]C Austin Zamarripa, Tory R Spindle, Destiny Schriefer, et al.
Frontiers in Neural Circuits|October 4, 2014
Optical suppression of drug-evoked phasic dopamine releaseJames E McCutcheon, Jackson J Cone, Christopher G Sinon, et al.
JAMA Network Open|July 20, 2022
Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail StoresTory R Spindle, Dennis J Sholler, Edward J Cone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 2020
Descending Dopaminergic Inputs to Reticulospinal Neurons Promote Locomotor MovementsDimitri Ryczko, Swantje Grätsch, Michael H Alpert, et al.
Journal of Analytical Toxicology|April 19, 2022
Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol ProductsCecilia L Bergeria, Tory R Spindle, Edward J Cone, et al.
Journal of Analytical Toxicology|June 5, 2021
Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis AdministrationDennis J Sholler, Tory R Spindle, Edward J Cone, et al.
Journal of Analytical Toxicology|January 20, 2006
Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicleR Sam Niedbala, Keith W Kardos, Dean F Fritch, et al.
Journal of Analytical Toxicology|November 8, 2025
Cannabidiol metabolites identified by LC-QTOF after controlled dosingSvante Vikingsson, Ruth E Winecker, Katherine Bollinger, et al.
Journal of Analytical Toxicology|January 5, 2018
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy AdultsNicolas J Schlienz, Edward J Cone, Evan S Herrmann, et al.
Journal of Analytical Toxicology|November 9, 2007
Cocaine and metabolites urinary excretion after controlled smoked administrationMarilyn A Huestis, W David Darwin, Eric Shimomura, et al.
Pageof 37

Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
Drug and Alcohol Dependence|May 29, 2025
Corrigendum to "A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults" [Drug Alcohol Depend. 272 (2025) 112676]C Austin Zamarripa, Tory R Spindle, Destiny Schriefer, et al.
Frontiers in Neural Circuits|October 4, 2014
Optical suppression of drug-evoked phasic dopamine releaseJames E McCutcheon, Jackson J Cone, Christopher G Sinon, et al.
JAMA Network Open|July 20, 2022
Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail StoresTory R Spindle, Dennis J Sholler, Edward J Cone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 2020
Descending Dopaminergic Inputs to Reticulospinal Neurons Promote Locomotor MovementsDimitri Ryczko, Swantje Grätsch, Michael H Alpert, et al.
Journal of Analytical Toxicology|April 19, 2022
Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol ProductsCecilia L Bergeria, Tory R Spindle, Edward J Cone, et al.
Journal of Analytical Toxicology|June 5, 2021
Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis AdministrationDennis J Sholler, Tory R Spindle, Edward J Cone, et al.
Journal of Analytical Toxicology|January 20, 2006
Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicleR Sam Niedbala, Keith W Kardos, Dean F Fritch, et al.
Journal of Analytical Toxicology|November 8, 2025
Cannabidiol metabolites identified by LC-QTOF after controlled dosingSvante Vikingsson, Ruth E Winecker, Katherine Bollinger, et al.
Journal of Analytical Toxicology|January 5, 2018
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy AdultsNicolas J Schlienz, Edward J Cone, Evan S Herrmann, et al.
Journal of Analytical Toxicology|November 9, 2007
Cocaine and metabolites urinary excretion after controlled smoked administrationMarilyn A Huestis, W David Darwin, Eric Shimomura, et al.
Pageof 37